Variant report
Variant | esv1828437 |
---|---|
Chromosome Location | chr6:65098768-65155219 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:6)
- LncRNA region (count:4)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:6 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:65105555..65108214-chr6:65112608..65114216,2 | K562 | blood: | |
2 | chr6:65090547..65093920-chr6:65096939..65100016,3 | MCF-7 | breast: | |
3 | chr6:65105555..65108214-chr6:65112608..65114216,2 | K562 | blood: | |
4 | chr6:65126062..65128864-chr6:65133526..65135852,2 | MCF-7 | breast: | |
5 | chr6:65126062..65128864-chr6:65133526..65135852,2 | MCF-7 | breast: | |
6 | chr10:122595797..122596436-chr6:65107139..65107964,2 | MCF-7 | breast: |
(count:4 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-PHF3-10 | chr6:65147436-65147564 | NONHSAT113362 |
2 | lnc-PHF3-2 | chr6:65122529-65122672 | ENSG00000232120.1 |
3 | lnc-PHF3-2 | chr6:65110209-65110322 | ENSG00000232120.1 |
4 | lnc-PHF3-10 | chr6:65145647-65145784 | NONHSAT113362 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs560606626 | chr6:65112436-65112437 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs560259651 | chr6:65112471-65112472 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs527743293 | chr6:65112480-65112481 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs543043934 | chr6:65112486-65112487 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs386702044 | chr6:65112557-65112558 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs956458 | chr6:65112558-65112559 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs567126648 | chr6:65112562-65112563 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs571429585 | chr6:65112580-65112581 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs33999835 | chr6:65112586-65112587 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs143935455 | chr6:65120416-65120417 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs559993172 | chr6:65120432-65120433 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs148224567 | chr6:65120471-65120472 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs185256489 | chr6:65120495-65120496 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs141488861 | chr6:65120499-65120500 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs190106996 | chr6:65120527-65120528 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs545775462 | chr6:65120529-65120530 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs9351246 | chr6:65120557-65120558 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs557587493 | chr6:65120610-65120611 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs535012021 | chr6:65120620-65120621 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs146183924 | chr6:65120623-65120624 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs116352975 | chr6:65120625-65120626 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs140179170 | chr6:65120644-65120645 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs557167419 | chr6:65120748-65120749 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs575429328 | chr6:65120757-65120758 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs377512421 | chr6:65120819-65120820 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs531642092 | chr6:65120839-65120840 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs542122642 | chr6:65120848-65120849 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs192774954 | chr6:65120873-65120874 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs563488275 | chr6:65120879-65120880 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs564148190 | chr6:65120927-65120928 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs530771502 | chr6:65120931-65120932 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs184808121 | chr6:65120944-65120945 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs7763168 | chr6:65120963-65120964 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs549478275 | chr6:65120972-65120973 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs4286758 | chr6:65121000-65121001 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs114846147 | chr6:65121047-65121048 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs530390268 | chr6:65121101-65121102 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs62418117 | chr6:65121113-65121114 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs548389051 | chr6:65121116-65121117 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs563574481 | chr6:65121151-65121152 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs36009422 | chr6:65121177-65121178 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs546993431 | chr6:65121193-65121194 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs530984742 | chr6:65121231-65121232 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs188308259 | chr6:65121290-65121291 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs180871238 | chr6:65121294-65121295 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs79445374 | chr6:65121306-65121307 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs370003984 | chr6:65121313-65121314 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs546928290 | chr6:65121431-65121432 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs77904377 | chr6:65121508-65121509 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs184890438 | chr6:65121524-65121525 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Cancer | 21637783 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 21364760 | CNVD |
Cancer | 20164920 | CNVD |
Prostate cancer | 16573809 | CNVD |
Ovarian cancer | 19835627 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cancer | 21183584 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16272173 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Epilepsy | 20502679 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:65112400-65112600 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
2 | chr6:65120400-65121800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
3 | chr6:65120800-65121800 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
4 | chr6:65121800-65124200 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
5 | chr6:65121800-65125000 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
6 | chr6:65124200-65124400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
7 | chr6:65124400-65124800 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
8 | chr6:65124800-65126600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
9 | chr6:65125000-65126600 | Enhancers | Fetal Brain Male | brain |
10 | chr6:65125000-65126600 | Enhancers | Fetal Lung | lung |
11 | chr6:65125000-65127000 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
12 | chr6:65125200-65125600 | Enhancers | Fetal Stomach | stomach |
13 | chr6:65125200-65126000 | Enhancers | Fetal Brain Female | brain |
14 | chr6:65125200-65126400 | Enhancers | Cortex derived primary cultured neurospheres | brain |
15 | chr6:65125400-65126400 | Enhancers | Adipose Nuclei | Adipose |
16 | chr6:65137200-65138000 | Enhancers | Fetal Lung | lung |
17 | chr6:65142600-65143200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
18 | chr6:65142800-65143200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
19 | chr6:65149000-65149400 | Enhancers | NHEK | skin |
20 | chr6:65149000-65149600 | Enhancers | HUVEC | blood vessel |
21 | chr6:65149200-65149800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
22 | chr6:65149400-65149800 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |